Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide in Acute Ischemic Stroke
NCT05630586Phase 2Recruiting
- Sponsor
- Aarhus University Hospital
- Start
- Apr 2023
- Primary completion
- Sep 2025
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of semaglutide in ischemic stroke, sponsored by Aarhus University Hospital. Started Apr 2023; status: recruiting.
02
Drugs
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05630586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05630586.